Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis

Clinical and Experimental Metastasis

Volumn 28, Issue 1, 2011, Pages 55-63

  Szasz, A M ^a   Tokes, A M ^a   Micsinai, M ^b   Krenacs, T ^a   Jakab, Cs ^c   Lukacs, L ^a   Nemeth, Zs ^a   Baranyai, Zs ^d   Dede, K ^d   Madaras, L ^a   Kulka, J ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NEW YORK UNIVERSITY   (United States)

^c SZENT ISTVÁN UNIVERSITY   (Hungary)

^d Uzsoki Memorial Hospital   (Hungary)

Author keywords

Breast cancer; Claudin; Lymph node metastasis; Prognosis; Tissue microarray

Indexed keywords

BETA CATENIN; CLAUDIN; CLAUDIN 1; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; UVOMORULIN;

ADULT; ARTICLE; BREAST; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LYMPH NODE METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGIONAL METASTASIS; TISSUE MICROARRAY;

EID: 79951675378     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9357-5     Document Type: Article

References (57)

1. Paul S, Dey A (2008) Wnt signaling and cancer development: therapeutic implication. Neoplasma 55(3):165-176
2. Morin PJ (1999) Beta-catenin signaling and cancer. Bioessays 21(12):1021-1030
3. Saldanha G, Ghura V, Potter L et al (2004) Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 151(1):157-164 (Pubitemid 39061293)
4. Hashizume R, Koizumi H, Ihara A et al (1996) Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology 29(2):139-146 (Pubitemid 26264438)
5. De Leeuw WJ, Berx G, Vos CB et al (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183(4):404-411 (Pubitemid 27509246)
6. Karayiannakis AJ, Nakopoulou L, Gakiopoulou H et al (2001) Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur J Surg Oncol 27(1):31-36 (Pubitemid 32229692)
7. Mastracci TL, Tjan S, Bane AL et al (2005) E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 18(6):741-751 (Pubitemid 40780507)
8. Kuroda H, Tamaru J, Takeuchi I et al (2006) Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch 448(4):500-505
9. Furuse M, Fujita K, Hiiragi T et al (1998) Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141(7):1539-1550 (Pubitemid 28309169)
10. Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186
11. Kulka J, Tokes AM (2005) Claudin expression in breast tumors. Hum Pathol 36(7):859 (author reply 60)
12. Morohashi S, Kusumi T, Sato F et al (2007) Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med 20(2):139-143
13. Kim TH, Huh JH, Lee S et al (2008) Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 53(1):48-55 (Pubitemid 351861978)
14. Tokes AM, Kulka J, Paku S et al (2005) Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7(2):R296-R305
15. Blackman B, Russell T, Nordeen SK et al (2005) Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors. Breast Cancer Res 7(2):R248-R255
16. Kominsky SL, Argani P, Korz D et al (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22(13):2021-2033 (Pubitemid 36523639)
17. Sauer T, Pedersen MK, Ebeltoft K et al (2005) Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16(4):193-198 (Pubitemid 41112978)
18. Blanchard AA, Skliris GP, Watson PH et al (2009) Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 454(6):647-656
19. Kulka J, Szasz AM, Nemeth Z et al (2009) Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol Oncol Res 15(1):59-64
20. Lanigan F, McKiernan E, Brennan DJ et al (2009) Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124(9):2088-2097
21. Soini Y (2005) Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46(5):551-560 (Pubitemid 40632312)
22. Park D, Karesen R, Axcrona U et al (2007) Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. APMIS 115(1):52-65 (Pubitemid 46066574)
23. Herschkowitz JI, Simin K, Weigman VJ et al (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8(5):R76
24. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K et al (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69(10):4116-4124
25. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869-10874 (Pubitemid 32878711)
26. Kulka J, Szasz A, Nemeth Z et al (2009) Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol Oncol Res 15(1):59-64
27. Eckel-Passow J, Lohse C, Sheinin Y et al (2010) Tissue microarrays: one size does not fit all. Diagn Pathol 5(1):48
28. Avninder S, Ylaya K, Hewitt S (2008) Tissue microarray: a simple technology that has revolutionized research in pathology. J Postgrad Med 54(2):158-162 (Pubitemid 351724207)
29. Drury S, Salter J, Baehner FL et al (2010) Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study. J Clin Pathol 63(6):513-517
30. Soini Y (2004) Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma. Hum Pathol 35(12):1531-1536 (Pubitemid 40017994)
31. Chao YC, Pan SH, Yang SC et al (2009) Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med 179(2):123-133
32. Fritzsche FR, Oelrich B, Johannsen M et al (2008) Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clin Cancer Res 14(21):7035-7042
33. Higashi Y, Suzuki S, Sakaguchi T et al (2007) Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. J Surg Res 139(1):68-76 (Pubitemid 46482569)
34. Lechpammer M, Resnick MB, Sabo E et al (2008) The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod Pathol 21(11):1320-1329
35. Resnick MB, Konkin T, Routhier J et al (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18(4):511-518 (Pubitemid 40478114)
36. Lanigan F, McKiernan E, Brennan DJ et al (2008) Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124:2088-2097
37. Krajewska M, Olson AH, Mercola D et al (2007) Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate. Prostate 67(9):907-910 (Pubitemid 46830626)
38. Landers KA, Samaratunga H, Teng L et al (2008) Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br J Cancer 99(3):491-501
39. Wang M, Xue L, Cao Q et al (2009) Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. Neoplasma 56(6):533-541
40. Orsulic S, Huber O, Aberle H et al (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112 (Pt 8): 1237):1237-1245 (Pubitemid 29218912)
41. Birchmeier C, Birchmeier W, Brand-Saberi B (1996) Epithelial-mesenchymal transitions in cancer progression. Acta Anat 156(3):217-226 (Pubitemid 27072577)
42. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14(6):818-829 (Pubitemid 351757205)
43. Hugo H, Ackland ML, Blick T et al (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213(2):374-383 (Pubitemid 47509716)
44. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17(5):548-558 (Pubitemid 41267170)
45. Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890
46. Onder TT, Gupta PB, Mani sa et al (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68(10):3645-3654
47. Creighton CJ, Chang JC, Rosen JM Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia
48. Perou C (2009) Overview of gene expression profiling and novel translational technologies in breast cancer. Cancer Res 69 (24-Meeting Abstracts): ES3-1
49. Szasz AM, Micsinai M, Tokes A et al (2009) Proteomic profiling of breast carcinomas based on claudin expression pattern. Cancer Res 69 (24-Meeting Abstracts): 6123
50. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70 (Pubitemid 30046295)
51. Yoshida R, Kimura N, Harada Y et al (2001) The loss of E-cadherin, alpha-and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol 18(3):513-520
52. Bukholm IK, Nesland JM, Karesen R et al (1998) E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 185(3):262-266 (Pubitemid 28320047)
53. Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17(5):499-508 (Pubitemid 41267164)
54. Goyal A, Martin TA, Mansel RE et al (2008) Real time PCR analyses of expression of E-cadherin, alpha-, beta-and gammacatenin in human breast cancer for predicting clinical outcome. World J Surg Oncol 6:56
55. Gyorffy H, Holczbauer A, Nagy P et al (2005) Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch 447(6):961-968 (Pubitemid 41719551)
56. Lodi C, Szabo E, Holczbauer A et al (2006) Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod Pathol 19(3):460-469 (Pubitemid 43277001)
57. Szabo I, Kiss A, Schaff Z et al (2009) Claudins as diagnostic and prognostic markers in gynecological cancer. Histol Histopathol 24(12):1607-1615